| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |